Steward Financial Group’s Bio-Rad Laboratories Class A BIO Stock Holding History

Steward Financial Group’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$5K	Buy	+15	New	+$5.79K	﹤0.01%	587
2023 Q2	–	Sell	-14	Closed	-$6K	–	518
2023 Q1	$6K	Buy	14 +8	+133%	+$3.75K	﹤0.01%	269
2022 Q4	$2K	Buy	+6	New	+$2.42K	﹤0.01%	310
2022 Q3	–	Sell	-9	Closed	-$4K	–	217
2022 Q2	$4K	Buy	+9	New	+$4.69K	﹤0.01%	367

Other funds holding BIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VAM

Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Steward Financial Group's BIO Position: Q3 2023 in Review

Steward Financial Group opened a new position in Bio-Rad Laboratories Class A (BIO) in Q3 2023: 15 shares worth $5K. The stake represents ﹤0.01% of the portfolio and ranks #587 among its holdings. This is a return to the name: Steward Financial Group previously reported a position in BIO as recently as Q1 2023.

Steward Financial Group first reported a position in BIO in Q2 2022 and has held it in 4 quarters since. The position peaked at $6K in Q1 2023. 468 funds tracked by Wall St. Rank hold BIO as of Q3 2023.

Steward Financial Group held 15 shares of Bio-Rad Laboratories Class A worth $5K as of Q3 2023.
Bio-Rad Laboratories Class A was a new Steward Financial Group position in Q3 2023.
Bio-Rad Laboratories Class A made up ﹤0.01% of Steward Financial Group's portfolio in Q3 2023, its #587 holding.
Steward Financial Group first reported a position in Bio-Rad Laboratories Class A in Q2 2022 and has held it in 4 quarters since.
Steward Financial Group's Bio-Rad Laboratories Class A position peaked at $6K in Q1 2023.
468 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2023.

Based on Steward Financial Group's 13F filing for Q3 2023, filed 23 Oct 2023.